Ovarian cancer results from the abnormal growth of cells in the ovaries. The affected cells, which are cancerous, may spread, destroying both nearby and distant areas in the body. Surgery is the ...

Seoul National University Hospital recently announced that it successfully performed the first high-level ovarian cancer ...

Stage IIIB: Your doctor saw cancer growths in your belly during surgery, but they’re less than 2 centimeters (cm) across. They may also be outside your liver and spleen and in your lymph nodes.

If you have cancer, you may need surgery at some point. Here’s what you need to know about the different types and the role they play in your care.

Ovarian cancer is often advanced at the time of diagnosis. Debulking is a surgical procedure that may prevent or delay disease progression. Debulking is a type of surgery that removes as many ...

Primary surgery for advanced ovarian cancer significantly improves progression-free survival but not overall survival compared with neoadjuvant chemo and interval cytoreductive surgery.

BOSTON — Patients with non-BRCA gene mutations undergoing risk-reduction surgery to prevent tubo-ovarian cancers showed no signs of tubo-ovarian high-grade serous carcinoma or serous tubal ...

Borderline ovarian tumours are abnormal cells that form in the tissue covering the ovary. They are not cancer and are usually cured with surgery. Around 15 out of 100 ovarian tumours (15%) are ...

Doctors use the International Federation of Gynecology and Obstetrics (FIGO) staging system to stage cancers in the: ovaries fallopian tubes; peritoneum; There are four stages, numbered 1 to 4. Stage ...

Recent research is digging into this fascinating organ across the medical field. It is featured in several recent research articles highlighting applications with brain cancer, lymphedema and ...

The wife and mother underwent emergency surgery to determine the cause of her pain. "They told me it was ovarian cancer, and I never thought that would be something I would be waking up to ...

Likewise, median overall survival (OS) was not significantly different between the two groups -- 48.9 months in the no-lymphadenectomy arm versus 58.8 months in the lymphadenectomy arm (HR 0.92 ...